Cardiac involvement in patients with Becker muscular dystrophy: New diagnostic and pathophysiological insights by a CMR approach

Journal of Cardiovascular Magnetic Resonance

Volumn 10, Issue 1, 2008, Pages

  Yilmaz, Ali ^a   Gdynia, Hans Jürgen ^b   Baccouche, Hannibal ^a   Mahrholdt, Heiko ^a   Meinhardt, Gabriel ^a   Basso, Cristina ^c   Thiene, Gaetano ^c   Sperfeld, Anne Dorte ^b   Ludolph, Albert C ^b   Sechtem, Udo ^a  

^a ROBERT BOSCH HOSPITAL   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM; CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM PENTETATE;

ADULT; ARTICLE; BECKER MUSCULAR DYSTROPHY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; HEART FAILURE; HEART INJURY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE INJURY; HUMAN; LABORATORY TEST; MALE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; ADOLESCENT; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; CONGESTIVE CARDIOMYOPATHY; DUCHENNE MUSCULAR DYSTROPHY; ELECTROCARDIOGRAPHY; GERMANY; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART STROKE VOLUME; HOSPITALIZATION; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PREDICTION AND FORECASTING; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; CARDIOMYOPATHY, DILATED; CHILD; CONTRAST MEDIA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; GADOLINIUM DTPA; GERMANY; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MUSCULAR DYSTROPHY, DUCHENNE; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT; YOUNG ADULT;

EID: 58749093466     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-10-50     Document Type: Article

References (39)

1. Emery AE: The muscular dystrophies. Lancet 2002, 359:687-695.
2. Bushby KM, Thambyayah M, Gardner-Medwin D: Prevalence and incidence of Becker muscular dystrophy. Lancet 1991, 337:1022-1024.
3. McNally EM: Duchenne muscular dystrophy: how bad is the heart? Heart 2008, 94:976-977. (Pubitemid 352039876)
4. Melacini P, Fanin M, Danieli GA, Villanova C, Martinello F, Miorin M, Freda MP, Miorelli M, Mostacciuolo ML, Fasoli G, Angelini C, Dalla Volta S: Myocardial involvement is very frequent among patients affected with subclinical Becker's muscular dystrophy. Circulation 1996, 94:3168-3175. (Pubitemid 26427483)
5. Cox G.F., Kunkel LM: Dystrophies and heart disease. Curr Opin Cardiol 1997, 12:329-343.
6. Jefferies JL, Eidem BW, Belmont JW, Craigen WJ, Ware SM, Fernbach SD, Neish SR, Smith EO, Towbin JA: Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy. Circulation 2005, 112:2799-2804.
7. Ramaciotti C, Heistein LC, Coursey M, Lemler MS, Eapen RS, Iannaccone ST, Scott WA: Left ventricular function and response to enalapril in patients with duchenne muscular dystrophy during the second decade of life. Am J Cardiol 2006, 98:825-827. (Pubitemid 44301021)
8. Goldberg LR, Jessup M: Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction. Circulation 2006, 113:2851-2860. (Pubitemid 44305298)
9. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B, American College of Cardiology; American Heart Association Task Force on Practice Guidelines; American College of Chest Physicians; International Society for Heart and Lung Transplantation; Heart RhythmSociety: ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005, 112:e154-e235.
10. Varghese A, Pennell DJ: Late gadolinium enhanced cardiovascular magnetic resonance in Becker muscular dystrophy. Heart 2004, 90:e59.
11. Mavrogeni S, Papavassiliou A, Cokkinos DV: Myocarditis in a patient with Duchenne muscular dystrophy detected by cardiovascular magnetic resonance and cardiac biopsy. Int J Cardiol 2007.
12. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I, et al.: Recommendations for quantitation of the left ventricle by twodimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989, 2:358-367.
13. Simonetti OP, Kim RJ, Fieno DS, Hillenbrand HB, Wu E, Bundy JM, Finn JP, Judd RM: An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001, 218:215-223. (Pubitemid 32151298)
14. Mahrholdt H, Goedecke C, Wagner A, Meinhardt G, Athanasiadis A, Vogelsberg H, Fritz P, Klingel K, Kandolf R, Sechtem U: Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004, 109:1250-1258. (Pubitemid 38379570)
15. Perloff JK, Roberts WC, de LA Jr, O'Doherty D: The distinctive electrocardiogram of Duchenne's progressive muscular dystrophy. An electrocardiographic-pathologic correlative study. Am J Med 1967, 42:179-188.
16. Sanyal SK, Johnson WW, Thapar MK, Pitner SE: An ultrastructural basis for electrocardiographic alterations associated with Duchenne's progressive muscular dystrophy. Circulation 1978, 57:1122-1129.
17. Nigro G, Comi LI, Politano L, Limongelli FM, Nigro V, De Rimini ML, Giugliano MA, Petretta VR, Passamano L, Restucci B, et al.: Evaluation of the cardiomyopathy in Becker muscular dystrophy. Muscle Nerve 1995, 18:283-291.
18. Daniels LB, Maisel AS: Natriuretic peptides. J Am Coll Cardiol 2007, 50:2357-2368.
19. Gabriel RS, Kerr AJ, Zeng I, Sharma V, Stewart R: B-type natriuretic peptide and left ventricular dysfunction on exercise echocardiography in patients with chronic aortic regurgitation. Heart 2007.
20. Sutton TM, Stewart RA, Gerber IL, West TM, Richards AM, Yandle TG, Kerr AJ: Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation. J Am Coll Cardiol 2003, 41:2280-2287.
21. Perloff JK, Henze E, Schelbert HR: Alterations in regional myocardial metabolism, perfusion, and wall motion in Duchenne muscular dystrophy studied by radionuclide imaging. Circulation 1984, 69:33-42. (Pubitemid 14215859)
22. Frankel KA, Rosser RJ: The pathology of the heart in progressive muscular dystrophy: epimyocardial fibrosis. Hum Pathol 1976, 7:375-386.
23. Silva MC, Meira ZM, Gurgel Giannetti J, da Silva MM, Campos AF, Barbosa Mde M, Starling Filho GM, Ferreira Rde A, Zatz M, Rochitte CE: Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy. J Am Coll Cardiol 2007, 49:1874-1879. (Pubitemid 46661108)
24. Khairallah M, Khairallah R, Young ME, Dyck JR, Petrof BJ, Des RC: Metabolic and signaling alterations in dystrophin-deficient hearts precede overt cardiomyopathy. J Mol Cell Cardiol 2007, 43:119-129. (Pubitemid 47069387)
25. Jung C, Martins AS, Niggli E, Shirokova N: Dystrophic cardiomyopathy: amplification of cellular damage by Ca2+ signalling and reactive oxygen species-generating pathways. Cardiovasc Res 2008, 77:766-773. (Pubitemid 351301866)
26. Mahrholdt H, Wagner A, Deluigi CC, Kispert E, Hager S, Meinhardt G, Vogelsberg H, Fritz P, Dippon J, Bock CT, Klingel K, Kandolf R, Sechtem U: Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 2006, 114:1581-1590. (Pubitemid 44547428)
27. Yilmaz A, Mahrholdt H, Athanasiadis A, Vogelsberg H, Meinhardt G, Voehringer M, Kispert EM, Deluigi C, Baccouche H, Spodarev E, Klingel K, Kandolf R, Sechtem U: Coronary vasospasm as the underlying cause for chest pain in patients with PVB19- myocarditis. Heart 2008, 94:1456-1463.
28. Bowles NE, Bowles KR, Towbin JA: The "final common pathway" hypothesis and inherited cardiovascular disease. The role of cytoskeletal proteins in dilated cardiomyopathy. Herz 2000, 25:168-175.
29. Towbin JA, Vatta M: Myocardial infarction, viral infection, and the cytoskeleton final common pathways of a common disease? J Am Coll Cardiol 2007, 50:2215-2217.
30. Badorff C, Lee GH, Lamphear BJ, Martone ME, Campbell KP, Rhoads RE, Knowlton KU: Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat Med 1999, 5:320-326. (Pubitemid 29124369)
31. Badorff C, Knowlton KU: Dystrophin disruption in enterovirusinduced myocarditis and dilated cardiomyopathy: from bench to bedside. Med Microbiol Immunol 2004, 193:121-126. (Pubitemid 38703780)
32. Lee GH, Badorff C, Knowlton KU: Dissociation of sarcoglycans and the dystrophin carboxyl terminus from the sarcolemma in enteroviral cardiomyopathy. Circ Res 2000, 87:489-495. (Pubitemid 30736742)
33. Xiong D, Yajima T, Lim BK, Stenbit A, Dublin A, Dalton ND, Summers- Torres D, Molkentin JD, Duplain H, Wessely R, Chen J, Knowlton KU: Inducible cardiac-restricted expression of enteroviral protease 2A is sufficient to induce dilated cardiomyopathy. Circulation 2007, 115:94-102. (Pubitemid 46058616)
34. Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ: Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 2005, 26:1461-1474. (Pubitemid 41373486)
35. Sen-Chowdhry S, Syrris P, Ward D, Asimaki A, Sevdalis E, McKenna WJ: Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression. Circulation 2007, 115:1710-1720. (Pubitemid 46648607)
36. Duboc D, Meune C, Lerebours G, Devaux JY, Vaksmann G, Becane HM: Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy. J Am Coll Cardiol 2005, 45:855-857. (Pubitemid 40342808)
37. Varghese A, Pennell DJ: Late gadolinium enhanced cardiovascular magnetic resonance in Becker muscular dystrophy. Heart 2004, 90:e59.
38. Occult cardiac contractile dysfunction in dystrophin-deficient children revealed by cardiac magnetic resonance strain imaging: Occult cardiac contractile dysfunction in dystrophin-deficient children revealed by cardiac magnetic resonance strain imaging. Circulation 2005, 112:2462-2467.
39. Mertens L, Ganame J, Claus P, Goemans N, Thijs D, Eyskens B, Van Laere D, Bijnens B, D'hooge J, Sutherland GR, Buyse G: Early Regional Myocardial Dysfunction in Young Patients With Duchenne Muscular Dystrophy. J Am Soc Echocardiogr 2008, 21:1049-1054.